Lipoprotein (a): a promising marker for residual cardiovascular risk assessment
A Cai, L Li, Y Zhang, Y Mo, W Mai, Y Zhou - Disease markers, 2013 - Wiley Online Library
Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
[PDF][PDF] Lipoprotein (a): A Promising Marker for Residual Cardiovascular Risk Assessment
A Cai, L Li, Y Zhang, Y Mo, W Mai… - Disease …, 2013 - pdfs.semanticscholar.org
Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
[HTML][HTML] Lipoprotein (a): a promising marker for residual cardiovascular risk assessment.
A Cai, L Li, Y Zhang, Y Mo, W Mai, Y Zhou - Disease Markers, 2013 - europepmc.org
Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
Lipoprotein (a): a promising marker for residual cardiovascular risk assessment
A Cai, L Li, Y Zhang, Y Mo, W Mai… - Disease …, 2013 - pubmed.ncbi.nlm.nih.gov
Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
Lipoprotein (a): A Promising Marker for Residual Cardiovascular Risk Assessment.
A Cai, L Li, Y Zhang, Y Mo, W Mai… - Disease Markers, 2013 - search.ebscohost.com
Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
[PDF][PDF] Lipoprotein (a): A Promising Marker for Residual Cardiovascular Risk Assessment
A Cai, L Li, Y Zhang, Y Mo, W Mai, Y Zhou - Disease Markers, 2013 - cyberleninka.org
Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
[HTML][HTML] Lipoprotein (a): A Promising Marker for Residual Cardiovascular Risk Assessment
A Cai, L Li, Y Zhang, Y Mo, W Mai, Y Zhou - Disease markers, 2013 - ncbi.nlm.nih.gov
Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
Lipoprotein (a): a promising marker for residual cardiovascular risk assessment.
A Cai, L Li, Y Zhang, Y Mo, W Mai, Y Zhou - Disease Markers, 2013 - europepmc.org
Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …
mortality worldwide, although optimal medical therapy has been prescribed for primary and …